Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
GLS.WS was delisted on the 3rd of January, 2023.
29 hedge funds and large institutions have $644K invested in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.
4% more funds holding
Funds holding: 28 → 29 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
75% less capital invested
Capital invested by funds: $2.54M → $644K (-$1.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$1.13M |
| 2 |
CAC
Cowen and Company
New York
|
+$8.69K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$642 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$114 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$6.17K |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$1.98K |
| 3 |
HF
HRT Financial
New York
|
-$963 |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$238 |
GLS.WS Hedge Fund Activity: Q4 2022 in Review
29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) for Q4 2022, worth a combined $644K — down 75% from $2.54M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GLS.WS positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was BlueCrest Capital Management, adding an estimated $1.13M. The largest seller was Shaolin Capital Management, cutting an estimated $6.17K.
- 29 institutional investors held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $644K of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 stock for Q4 2022, down 75% quarter-over-quarter.
- 1 fund opened new Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 buyer in Q4 2022 was BlueCrest Capital Management, an estimated $1.13M added.
- The largest Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 seller in Q4 2022 was Shaolin Capital Management, an estimated $6.17K sold.
Based on aggregated 13F filings for Q4 2022.